CURRENT LOCATION:HOME > NEWS >
SEVIA Held FDA Deeming Regulations Conference in Shenzhen
发布日期 : 2016-09-14 浏览次数 : 编辑:Vivappower

On September 3rd, SEVIA (Shenzhen Electronic Vaporizer Industry Association) held a conference in Shenzhen, the heart of electronic cigarette industry, to discuss the FDA deeming regulations and the latest status of the lawsuit that SEVIA USA financially supported. 
Dimitris Agrafiotis, the Chairman of SEVIA USA and an activist in the electronic cigarette industry, explained SEVIA USA’s accomplishment so far and the challenges that lay ahead. Dimitris has very kindly provided the PowerPoint presentation that was given at the meeting for your review.
 
The presentation covers important topics including SEVIA financing, VTA/AVA/CASAA, guidance to manufacturers/distributors/shop owners, information about the second lawsuit filed and much more.
Azim Chowdhury, partner of Keller and Heckman LLP at Washington office and expert of FDA regulations, explained the latest interpretation of the FDA deeming regulations from legal point of view.